BROOKS Intraday Analysis...

BROOKS Share Price

Open 109.30 Change Price %
High 109.30 1 Day -3.70 -3.43
Low 103.05 1 Week -1.35 -1.28
Close 104.20 1 Month -1.55 -1.47
Volume 53403 1 Year -9.95 -8.72
52 Week High 194.70
52 Week Low 95.15
BROOKS Important Levels
Resistance 2 109.99
Resistance 1 107.61
Pivot 105.52
Support 1 100.79
Support 2 98.41
NSE INDIA Most Active Stocks
JPASSOCIAT 17.05 -6.06%
INFIBEAM 119.85 -16.42%
SUZLON 16.10 -1.23%
RCOM 19.90 0.25%
UNITECH 6.65 -4.32%
IBREALEST 201.50 -7.59%
GMRINFRA 16.45 -1.79%
SOUTHBANK 28.60 -2.39%
HFCL 27.95 -4.93%
CAPACITE 342.55 37.02%
More..
NSE INDIA Top Gainers Stocks
CAPACITE 342.55 37.02%
NAGREEKEXP 35.15 19.97%
SHOPERSTOP 500.40 19.68%
LCCINFOTEC 0.35 16.67%
VISASTEEL 19.90 15.70%
TVTODAY 414.45 15.37%
GUFICBIO 83.25 11.90%
SCI 97.95 11.88%
SCI 97.95 11.88%
SCI 97.95 11.88%
More..
NSE INDIA Top Losers Stocks
KSERASERA 0.10 -33.33%
TIFIN 589.55 -25.67%
ADHUNIKIND 63.30 -19.97%
PRAKASHSTL 0.25 -16.67%
INFIBEAM 119.85 -16.42%
VICEROY 19.40 -11.82%
PREMIERPOL 32.35 -11.37%
DAMODARIND 100.25 -10.01%
TINPLATE 224.65 -9.76%
VASWANI 16.90 -9.63%
More..

Brooks Laboratories Limited (NSE: BROOKS)

BROOKS Technical Analysis 5
As on 25th Sep 2017 BROOKS Share Price closed @ 104.20 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 130.15 & Strong Sell for SHORT-TERM with Stoploss of 111.59 we also expect STOCK to react on Following IMPORTANT LEVELS.
BROOKS Target for September
1st Target up-side 120.4
2nd Target up-side 127.58
3rd Target up-side 134.76
1st Target down-side 99.9
2nd Target down-side 92.72
3rd Target down-side 85.54
BROOKS Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 42.07 Sideways
MFI (14) MFI is 43.98 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is 17.41 Range Bound
PSAR Stoploss For Short Sell 120.56
10 Day Avg Volume Traded -58.69 % Less then 10 Day Average Volume
BROOKS Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
BROOKS Address
BROOKS
N/A
BROOKS Latest News
Stocks to Watch: NXP Semi, Hewlett-Packard, Johnson & Johnson   Wall Street Journal (blog)   - 02nd Mar 15
Brooks Labs standalone Dec '14 sales at Rs 23.68 crore   Moneycontrol.com   - 17th Feb 15
Tesco recalls fruit drinks over 'foreign bodies' and 'unusual smell'   Daily Mail   - 28th Jan 15
Sebi slaps Rs 11.80 cr penalty on Brooks Labs and 5 executives   Business Standard   - 12th Jan 15
Brooks Laboratories Ltd clarifies on SEBI order against the firm   Equity Bulls   - 05th Dec 14
Clarification sought from Brooks Laboratories Ltd   Hindu Business Line   - 03rd Dec 14
Sebi passes orders against 8 companies for non-disclosures in IPO   Economic Times   - 02nd Dec 14
Brooks Laboratories appoints SGCO & Co as statutory auditors   Moneycontrol.com   - 12th Aug 14
SEBI imposes Rs. 53.5 cr fine in Brooks Lab IPO case   Hindu Business Line   - 31st Dec 13
IPO Crackdown-2: Brooks Laboratories   Moneylife Personal Finance site and magazine   - 13th Jan 12
Interactive Technical Analysis Chart Brooks Laboratories Limited ( BROOKS NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Brooks Laboratories Limited
BROOKS Business Profile
Brooks Labs is in the Pharmaceuticals sector. Brooks Laboratories Ltd. was established in 2002 and maintains its strong presence in the Pharmaceutical industry as a Contract Manufacturing Company since its inception. Brooks Laboratories Ltd is a Research and Development driven Pharmaceutical manufacturing company, in last 6 years company has successfully established itself as a reputed Contract Manufacturing company for latest molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups. The current market capitalisation stands at Rs 28.65 crore.The company has reported a standalone sales of Rs 25.20 crore and a Net Profit of Rs 1.9 crore for the quarter ended Sep 2013. The company management includes Atul Ranchal - Chairman, Rajesh Mahajan - Managing Director, D S Maity - Director & CEO, Rajnish Bedi - Independent Director, Bhaskar Sharma - Additional Director. It is listed on the BSE with a BSE Code of 533543 and the NSE with an NSE Code of BROOKS. Its Registered office is at Village Kishanpura, Nalagarh Road,,Baddi Solan District,Himachal Pradesh - 174101.